WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Seahorse Bioscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, November 5, 2003, 23(31):9981-9986

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (47)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margolis, E. B.
Right arrow Articles by Fields, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margolis, E. B.
Right arrow Articles by Fields, H. L.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
{kappa}-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons

Elyssa B. Margolis,1 Gregory O. Hjelmstad,2 Antonello Bonci,2 and Howard L. Fields1,2

1Joint University of California San Francisco/University of California, Berkeley Bioengineering Graduate Group, San Francisco, California 94143-0775, and 2Department of Neurology, Wheeler Center for the Neurobiology of Addiction, Ernest Gallo Clinic and Research Center, University of California, San Francisco, California 94143-0114

Dopaminergic neurons of the ventral tegmental area (VTA) play a critical role in motivation and reinforcement of goal-directed behaviors. Furthermore, excitation of these neurons has been implicated in the addictive process initiated by drugs such as morphine that act at the µ-opioid receptor (MOR). In contrast, {kappa}-opioid receptor (KOR) activation in the VTA produces behavioral actions opposite to those elicited by MOR activation. The mechanism underlying this functional opposition, however, is poorly understood. VTA neurons have been categorized previously as principal, secondary, or tertiary on the basis of electrophysiological and pharmacological characteristics. In the present study using whole-cell patch-clamp recordings, we demonstrate that a selective KOR agonist (U69593, 1 µM) directly inhibits a subset of principal and tertiary but not secondary neurons in the VTA. This KOR-mediated inhibition occurs via the activation of a G-protein-coupled inwardly rectifying potassium channel and is blocked by the selective KOR antagonist nor-Binaltorphimine (100 nM). Significantly, regardless of cell class, KOR-mediated inhibition was found only in tyrosine hydroxylase-immunoreactive and thus dopaminergic neurons. In addition, we found a subset of principal neurons that exhibited both disinhibition by a selective MOR agonist ([D-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin) (3 µM) and direct inhibition by KOR agonists. These results provide a cellular mechanism for the opposing behavioral effects of KOR and MOR agonists and shed light on how KORs might regulate the motivational effects of both natural rewards and addictive drugs.

Key words: ventral tegmental area; midbrain; dopamine; {kappa}-opioid; µ-opioid; U69593; DAMGO; postsynaptic; in vitro

Received July 7, 2003; revised September 4, 2003; accepted September 10, 2003.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
C. Xiao, C. Zhou, K. Li, D. L. Davies, and J. H. Ye
Purinergic Type 2 Receptors at GABAergic Synapses on Ventral Tegmental Area Dopamine Neurons Are Targets for Ethanol Action
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 196 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. B. Margolis, J. M. Mitchell, J. Ishikawa, G. O. Hjelmstad, and H. L. Fields
Midbrain Dopamine Neurons: Projection Target Determines Action Potential Duration and Dopamine D2 Receptor Inhibition
J. Neurosci., September 3, 2008; 28(36): 8908 - 8913.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
C. H. Yang, B. H. Lee, and S. H. Sohn
A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 257 - 266.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K.-Y. Li, C. Xiao, M. Xiong, E. Delphin, and J.-H. Ye
Nanomolar Propofol Stimulates Glutamate Transmission to Dopamine Neurons: A Possible Mechanism of Abuse Potential?
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 165 - 174.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. L. Poole, J. Deuchars, D. I. Lewis, and S. A. Deuchars
Subdivision-Specific Responses of Neurons in the Nucleus of the Tractus Solitarius to Activation of Mu-Opioid Receptors in the Rat
J Neurophysiol, November 1, 2007; 98(5): 3060 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
C. P. Ford, M. J. Beckstead, and J. T. Williams
Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents
J Neurophysiol, January 1, 2007; 97(1): 883 - 891.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. B. Margolis, H. Lock, G. O. Hjelmstad, and H. L. Fields
The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
J. Physiol., December 15, 2006; 577(3): 907 - 924.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. D. Gale and D. J. Perkel
Physiological Properties of Zebra Finch Ventral Tegmental Area and Substantia Nigra Pars Compacta Neurons
J Neurophysiol, November 1, 2006; 96(5): 2295 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Wang, S. Haj-Dahmane, and R.-Y. Shen
Effects of Prenatal Ethanol Exposure on the Excitability of Ventral Tegmental Area Dopamine Neurons in Vitro
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 857 - 863.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. Schilstrom, R. Yaka, E. Argilli, N. Suvarna, J. Schumann, B. T. Chen, M. Carman, V. Singh, W. S. Mailliard, D. Ron, et al.
Cocaine Enhances NMDA Receptor-Mediated Currents in Ventral Tegmental Area Cells via Dopamine D5 Receptor-Dependent Redistribution of NMDA Receptors.
J. Neurosci., August 15, 2006; 26(33): 8549 - 8558.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. P. Ford, G. P. Mark, and J. T. Williams
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.
J. Neurosci., March 8, 2006; 26(10): 2788 - 2797.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. B. Margolis, H. Lock, V. I. Chefer, T. S. Shippenberg, G. O. Hjelmstad, and H. L. Fields
{kappa} opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
PNAS, February 21, 2006; 103(8): 2938 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
W. A. Carlezon Jr., C. Beguin, J. A. DiNieri, M. H. Baumann, M. R. Richards, M. S. Todtenkopf, R. B. Rothman, Z. Ma, D. Y.-W. Lee, and B. M. Cohen
Depressive-Like Effects of the {kappa}-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 440 - 447.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. E. Bartlett, J. Enquist, F. W. Hopf, J. H. Lee, F. Gladher, V. Kharazia, M. Waldhoer, W. S. Mailliard, R. Armstrong, A. Bonci, et al.
Dopamine responsiveness is regulated by targeted sorting of D2 receptors
PNAS, August 9, 2005; 102(32): 11521 - 11526.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
H. D. Mansvelder
Yin and Yang of VTA Opioid Signaling. Focus on "Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons"
J Neurophysiol, June 1, 2005; 93(6): 3046 - 3047.
[Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons
J Neurophysiol, June 1, 2005; 93(6): 3086 - 3093.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
I. D. Meng, J. P. Johansen, I. Harasawa, and H. L. Fields
Kappa Opioids Inhibit Physiologically Identified Medullary Pain Modulating Neurons and Reduce Morphine Antinociception
J Neurophysiol, March 1, 2005; 93(3): 1138 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Dong, D. Saal, M. Thomas, R. Faust, A. Bonci, T. Robinson, and R. C. Malenka
Cocaine-induced potentiation of synaptic strength in dopamine neurons: Behavioral correlates in GluRA(-/-) mice
PNAS, September 28, 2004; 101(39): 14282 - 14287.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. L. Borgland, R. C. Malenka, and A. Bonci
Acute and Chronic Cocaine-Induced Potentiation of Synaptic Strength in the Ventral Tegmental Area: Electrophysiological and Behavioral Correlates in Individual Rats
J. Neurosci., August 25, 2004; 24(34): 7482 - 7490.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. A. Kim, K. A. Pollak, G. O. Hjelmstad, and H. L. Fields
A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism
PNAS, April 13, 2004; 101(15): 5664 - 5669.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-